0001485003-16-000185.txt : 20160928 0001485003-16-000185.hdr.sgml : 20160928 20160928161400 ACCESSION NUMBER: 0001485003-16-000185 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160920 FILED AS OF DATE: 20160928 DATE AS OF CHANGE: 20160928 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 252025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-9911 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clairmark Investments Ltd. CENTRAL INDEX KEY: 0001652078 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 161907093 BUSINESS ADDRESS: STREET 1: 305 MILNER AVENUE, SUITE 914 CITY: TORONTO STATE: A6 ZIP: M1B3V4 BUSINESS PHONE: 416-940-6995 MAIL ADDRESS: STREET 1: 305 MILNER AVENUE, SUITE 914 CITY: TORONTO STATE: A6 ZIP: M1B3V4 3 1 wf-form3_147509362699302.xml FORM 3 X0206 3 2016-09-20 0 0001485003 Eleven Biotherapeutics, Inc. EBIO 0001652078 Clairmark Investments Ltd. C/O ELEVEN BIOTHERAPEUTICS, INC. 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142 0 0 1 0 Common Stock 3582328 D The reporting person acquired 3,582,328 shares of issuer common stock in exchange for an 89.2585% interest in Viventia Bio, Inc. pursuant to the issuer's purchase of all outstanding capital stock of Viventia Bio Inc. on September 20, 2016. Of the 3,582,328 shares issued to the reporting person in the transaction 358,232 shares re currently being held in escrow and are subject to forfeiture during the 15-month period following the transaction to satisfy claims arising as a result of Viventia Bio Inc.'s or the reporting person's breach of any of their respective representations, warranties or covenants in the share purchase agreement. CLAIRMARK INVESTMENTS LTD. /s/ Leslie L. Dan, President 2016-09-22